Compare AstraZeneca plc (AZN) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs VF Corp — how do they compare? AstraZeneca plc trades at $158.1 (market cap $250.84B), while VF Corp trades at $14.9 (market cap $5.86B). The key difference: AstraZeneca plc is far larger — about 42.8× VF Corp's market cap, and VF Corp pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| AZN | VFC | |
|---|---|---|
Market Cap | $250.84B | $5.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $21.55 |
52-Week Low | $147.06 | $12.21 |
Enterprise Value | $278.12B | $10.14B |
Dividend Yield | 1.97% | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
